Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cresco Labs (CRLBF) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Cresco Labs (CRLBF) over the last 6 years, with Q3 2025 value amounting to $61.5 million.

  • Cresco Labs' Operating Expenses fell 829.12% to $61.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.3 million, marking a year-over-year decrease of 125.39%. This contributed to the annual value of $257.2 million for FY2024, which is 4287.69% down from last year.
  • Cresco Labs' Operating Expenses amounted to $61.5 million in Q3 2025, which was down 829.12% from $67.1 million recorded in Q2 2025.
  • Over the past 5 years, Cresco Labs' Operating Expenses peaked at $372.3 million during Q3 2021, and registered a low of $61.5 million during Q3 2025.
  • For the 5-year period, Cresco Labs' Operating Expenses averaged around $106.1 million, with its median value being $82.3 million (2023).
  • Per our database at Business Quant, Cresco Labs' Operating Expenses soared by 61729.18% in 2021 and then tumbled by 7774.29% in 2022.
  • Over the past 5 years, Cresco Labs' Operating Expenses (Quarter) stood at $94.5 million in 2021, then skyrocketed by 144.73% to $231.2 million in 2022, then tumbled by 70.13% to $69.0 million in 2023, then dropped by 6.41% to $64.6 million in 2024, then decreased by 4.78% to $61.5 million in 2025.
  • Its Operating Expenses stands at $61.5 million for Q3 2025, versus $67.1 million for Q2 2025 and $65.0 million for Q1 2025.